BLFS stock forecast
Our latest prediction for BioLife Solutions, Inc.'s stock price was made on the Nov. 20, 2019 when the stock price was at 15.55$.
In the short term (2weeks), BLFS's stock price should outperform the market by 3.13%. During that period the price should oscillate between -6.62% and +9.42%.
In the medium term (3months), BLFS's stock price should outperform the market by 4.17%. During that period the price should oscillate between -15.87% and +24.47%.Get email alerts
About BioLife Solutions, Inc.
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.
At the moment the company generates 25M USD in revenues.
On its last earning announcement, the company reported a profit of 0.47$ per share.
The book value per share is 1.10$
Three months stock forecastNov. 20, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|